Nagelista
Operating. Nagelista sells to customers and is run by Inovativi. Order volumes, revenue and conversion figures are not published.
Owned business
Design-led press-on nails, handmade in Kosovo and fitted to each customer's hands, sold directly to consumers in Europe.
Nagelista is the clearest example of how we build: a physical product, digital customer acquisition, customer automation and European fulfilment, run as one operation.
Operating. Nagelista sells to customers and is run by Inovativi. Order volumes, revenue and conversion figures are not published.
Wider European reach, with Germany, Austria and Switzerland first, and more automation in intake and customer communication.
Press-on nails are an alternative to salon visits, but most are sold in standard sizes that fit few hands well. A personalised set needs the right design and a fit that actually fits, and then production, cross-border shipping and aftercare for every single order. That is an operations problem as much as a product problem.
Customers choose a design or send their own inspiration, upload reference photos of their hands and receive a handmade ten-piece set sized to their nails. Sets are made in Kosovo and shipped to customers in the EU, with VAT settled at checkout for EU deliveries. Each customer's fit is kept, so the second order is simpler than the first.
Software and AI handle the customer-facing guidance, photo-assisted fit intake, style suggestions and the order flow. One backend connects the storefront to production, quality control, export logistics and customer history, so nothing is retyped between steps.
A person verifies every fit. Sizing is photo-assisted, never automatic, and no guaranteed fit is claimed. Every set is made by hand and checked before it ships.
Next steps
Operating. Nagelista sells to customers and is run by Inovativi. Order volumes, revenue and conversion figures are not published.
Bring a distribution channel, production capability or specialist expertise. Name the venture and the contribution you want to make.
Discuss a named venture, its current stage and next milestone. Ask about the evidence available and the role capital could play.